AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Department of Gastroenterology and Liver, Liverpool Hospital, Sydney, New South Wales, Australia.
J Gastroenterol Hepatol. 2023 Aug;38(8):1211-1217. doi: 10.1111/jgh.16248. Epub 2023 Jun 1.
Alcohol consumption is a major cause of cirrhosis and hepatocellular carcinoma (HCC). The prevalence of alcohol-associated hepatocellular carcinoma (aHCC) varies worldwide but is highest in Eastern Europe. Alcohol is the second fastest-growing cause of age-standardized liver cancer mortality with tumors more often diagnosed outside surveillance protocols and at a more advanced stage. Risk factors for aHCC include greater amounts of alcohol consumption, sex, and certain genetic polymorphisms. Smoking, concomitant liver disease, obesity, and diabetes act synergistically in increasing the risk of HCC in alcohol-associated liver disease. Alcohol-related hepatocarcinogenesis results from the complex interactions of several mechanistic pathways. Although not completely understood, underlying mechanisms include acetaldehyde-related hepatotoxicity, oxidative stress, activation of the innate immune system, and alterations of the host microbiome.
饮酒是肝硬化和肝细胞癌(HCC)的主要病因。酒精相关性肝细胞癌(aHCC)的流行率在全球范围内有所不同,但在东欧最高。酒精是导致年龄标准化肝癌死亡率增长第二快的原因,其肿瘤更常在监测方案之外诊断,且处于更晚期。aHCC 的危险因素包括饮酒量更大、性别和某些遗传多态性。吸烟、同时存在的肝脏疾病、肥胖和糖尿病协同作用,增加了酒精性肝病中 HCC 的风险。酒精相关性肝癌的发生是由几个机制途径的复杂相互作用引起的。尽管尚未完全了解,但潜在机制包括乙醛相关肝毒性、氧化应激、固有免疫系统激活和宿主微生物组的改变。